Study the Effect of Plant-based Beverage Consumption on the Gut Microbiome in Healthy Adults

Analysis of the Intestinal Flora Composition After Consumption of Plant-based Beverages

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07730229

Enrollment

Registered

2026-07-28

Start date

2025-11-10

Completion date

2026-07-31

Last updated

2026-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Microbiome, Plant-based Milk

Brief summary

The goal of this intervention study is to analyse the microbiota composition after the plant-based beverage consumption. The main questions are to evaluate if the plant-based beverage can have a beneficial effect on the gut microbiota. Participants will consume different plant-based beverages for two weeks, and microbiota will be analysed. Researchers will compare the microbiota composition before and after consumption.

Interventions

DIETARY_SUPPLEMENTplant-based beverage

Participants will consume the assigned plant-based beverages for two weeks.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

\- 18-65 years of age. • must be able to complete the form digitally.

Exclusion criteria

* Must not be diagnosed with gastrointestinal diseases, autoimmune diseases or have diseases or medications that cause immune deficiency, such as MS, type 1 diabetes, cancer or HIV * must not take antibiotics during the study period * must not have a milk protein allergy

Design outcomes

Primary

Measure	Time frame	Description
Change in gut microbiome alpha diversity	up to 24 weeks	Gut microbiome alpha diversity will be assessed using 16S rRNA gene sequencing and quantified using alpha diversity indices (e.g., Shannon diversity index).
Change in gut microbiome beta diversity	Upto 24 weeks	Gut microbiome beta diversity will be assessed using 16S rRNA gene sequencing by comparing community composition between samples using beta diversity distance metrics (e.g., Bray-Curtis dissimilarity or UniFrac distances).

Secondary

Measure	Time frame	Description
Change in the relative abundance of gut bacterial taxa	Baseline to Week 24	The relative abundance of bacterial taxa identified by 16S rRNA gene sequencing will be compared between study groups and over time.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 29, 2026